Eric Lefkofsky Dedicated to Making Cancer Treatment More Effective

Everyone knows someone who has fought cancer, almost forty percent of adults in the United States will face a diagnosis of cancer in their lifetime. During 2014 there were approximately fourteen and a half million citizens that had cancer according to the National Cancer Institute. By 2024 that number is expected to increase to over nineteen million. The advances made by Tempus and companies like it make the prognosis better though. Tempus, which Eric Lefkofsky co-cofounded, is leading the way in precision medicine that is data enabled.

Even with the emergence of electronic health records (EHRs) the healthcare industry has not kept up with modern technology. There are holds in the digital technology and collection of data even with the massive amounts of data generated as it is collected there is not a streamlined and effective way to keep the information so that it is used effectively. This is where the impressive goal that Tempus has comes in. The company developed a way to analyze the molecular and clinical data of patients.

The hurdle was affordable and accessible medical and clinical data even though they company could develop analytics software. Tempus also had to overcome the way that information is being collected and stored for cancer patients. It is typically physical notes or progress notes which are difficult to analyze because they are free text fields.

Tempus is making progress at getting all the data from cancer patients records centralized and easily accessible so that the treatments are more effective. Having this data readily available to everyone who treats the cancer patients will make the treatment for effective as it will be easier to see what progress, and side effects where seen from which treatments. There will be genome sequencing combined with the data so that researchers can find better ways to treat cancer and other diseases.

Details Eric: Facebook.com/eplefkofsky/

José Auriemo Neto: CEO of Brazil’s JHSF Participacoes SA

José Auriemo Neto is a very successful Brazilian business executive. He is chairman and CEO of JHSF Participacoes SA, one of Brazil’s top real estate companies. JHSF Participacoes specializes in the development of high-end commercial and residential properties. Ever since José Auriemo Neto joined the company in 1993, he has helped it to expand into new areas and increase its influence, improve its public image and become more powerful. A graduate of Sao Paulo based Fundação Armando Álvares Penteado (FAAP) University, Neto has proven to be innovative, creative and motivated right from the start.

In 1997, just a few years after joining the company, José Auriemo Neto created Parkbem, a parking lot management company. This marked the founding of JHSF Participacoes SA’s services department. The services department quickly became a huge success and gained Neto added respect within the company. The next year, José Auriemo Neto once again broke new ground for the company. He was able to get the rights to develop Shopping Santa Cruz and guide it to its successful completion. This was JHSF Participacoes SA’s first shopping destination.

In 2009, Neto signed Jimmy Choo, Pucci and Hermes to exclusive partnership agreements and opened the first retail outlets for the three luxury brands at Cidade Jadrim, a shopping complex owned by JHSF. It was JHSF’s first foray into the retail industry. He further solidified their position as a retail industry leader by forming a partnership with Valentino and launching Brazil’s first R.E.D. Valentino and Valentino stores. JHSF now has an extensive retail and shopping portfolio the includes the Manus-based Ponta Negra shopping centre, the Metrô Tucuruv and the Bela Vista in Salvador.

José Auriemo Neto’s role with the company now includes administering JHSF’s shopping and retail portfolio and overseeing their interests in public developments, hotels and office buildings.

https://www.crunchbase.com/person/jose-auriemo-neto#/entity